By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardiac Dimensions, Inc. 

5540 Lake Washington Boulevard NE

Krikland  Washington  98033  U.S.A.
Phone: 425-822-1090 Fax:


Medical Device

Company News
Cardiac Dimensions Announces Investigational Device Exemption Approval From FDA To Conduct U.S. Pivotal Study Of The Carillon Mitral Contour System For Functional Mitral Regurgitation 12/1/2016 12:09:57 PM
Cardiac Dimensions Release: Carillon Mitral Contour System Associated With Significant Improvement Of Functional Mitral Regurgitation 2/24/2016 9:47:22 AM
Cardiac Dimensions Taps a New CEO 12/18/2015 7:46:46 AM
LSP Invests In Cardiac Dimensions, A Pioneer In Heart Failure Treatment 3/13/2015 8:06:46 AM
Cardiac Dimensions Snags $43 Million for Carillon Mitral Valve Implant 3/11/2015 7:24:16 AM
Cardiac Dimensions, Inc. Expands Equity Financing To $28.5 Million 10/7/2014 8:07:59 AM
Cardiac Dimensions, Inc. Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 9/17/2014 8:35:53 AM
Cardiac Dimensions, Inc. Completes $20 Million Equity Financing 4/16/2014 6:45:08 AM
Cardiac Dimensions, Inc. Completes Patient Enrollment in TITAN II Clinical Trial 3/8/2013 9:44:27 AM
Cardiac Dimensions, Inc. Initiates European Commercialization of CARILLON® Mitral Contour System® 9/28/2012 11:17:54 AM